Loading…
UnitedHealth Group Incorporated is projected to rise to $537.45 by 2027, a +29% move from its current price of $417.64. UNH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $412.23 | $417.81 | $423.46 | +0.04% |
| Jul 30 | $410.10 | $417.97 | $425.99 | +0.08% |
| Jul 31 | $408.51 | $418.14 | $427.99 | +0.12% |
| Aug 1 | $407.20 | $418.30 | $429.70 | +0.16% |
| Aug 2 | $406.07 | $418.47 | $431.24 | +0.20% |
| Aug 3 | $405.07 | $418.63 | $432.65 | +0.24% |
| Aug 4 | $404.16 | $418.80 | $433.96 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $404.16 | $418.80 | $433.96 | +0.28% |
| Week 2 | $399.35 | $419.96 | $441.63 | +0.56% |
| Week 3 | $395.96 | $421.12 | $447.89 | +0.83% |
| Week 4 | $393.29 | $422.29 | $453.43 | +1.11% |
| Week 5 | $391.08 | $423.46 | $458.52 | +1.39% |
| Week 6 | $389.20 | $424.63 | $463.29 | +1.67% |
| Week 7 | $387.57 | $425.81 | $467.83 | +1.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.
The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children’s Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs.
UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group Incorporated launched on January 1, 1977.
UnitedHealth Group Incorporated trades as UNH and sits in the healthcare sector. Its current price is $436.35 with a market capitalization of $396.27B and a rank of 27. The stock’s near-term technical picture shows bullish tendencies, while the longer-term forecast depicts steady upside through 2050.
A major floor 38.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.3% below — buyers have tended to step in here.
The nearest ceiling, 4.5% above — a clean break opens room to run.
A major ceiling 8.9% above — clearing it would confirm fresh momentum.
Key UNH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UNH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $425.92 | Sell | $422.56 | Sell |
| MA 10 | $424.43 | Sell | $423.79 | Sell |
| MA 20 | $424.44 | Sell | $421.61 | Sell |
| MA 50 | $407.93 | Buy | $404.64 | Buy |
| MA 100 | $361.98 | Buy | $379.46 | Buy |
| MA 200 | $343.52 | Buy | $364.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.44 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -110.20 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -2.11 | Sell |
| ROC (12) | -3.25 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 7.85 | Buy |
| Ultimate (7,14,28) | 44.29 | Neutral |
| Momentum (10) | -11.45 | Sell |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 422.24 | Sell |
| ADX (14) | 19.03 | Neutral |
| ATR (14) | 5.67 | Info |
Technical sentiment is BULLISH with RSI14 at 60. The 50-day simple moving average is $405.30 and the 200-day simple moving average is $342.23. Support sits at $399.53, with resistance at $436.35. The 30-day price range is $397.16 to $479.41, indicating a tolerant range for near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $259.02 | $417.64 | $557.50 | 0% | Neutral | |
| $440.59 | $537.45 | $685.13 | +29% | Bullish | |
| $475.32 | $590.83 | $773.81 | +41% | Bullish | |
| $552.26 | $697.13 | $932.66 | +67% | Bullish | |
| $617.29 | $789.80 | $1,075.79 | +89% | Bullish | |
| $728.35 | $943.33 | $1,305.33 | +126% | Bullish | |
| $904.42 | $1,184.64 | $1,662.67 | +184% | Bullish | |
| $967.49 | $1,280.63 | $1,820.75 | +207% | Bullish | |
| $1,073.64 | $1,435.30 | $2,065.13 | +244% | Bullish | |
| $1,196.38 | $1,614.56 | $2,348.99 | +287% | Bullish | |
| $1,926.36 | $2,711.66 | $4,134.75 | +549% | Bullish | |
| $3,444.39 | $5,200.33 | $8,500.72 | +11.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $259.02 | $417.64 | $489.79 | +0.00% |
| August 2026 | $368.81 | $430.33 | $511.93 | +3.04% |
| September 2026 | $369.03 | $432.98 | $519.76 | +0.61% |
| October 2026 | $365.86 | $431.19 | $521.38 | -0.41% |
| November 2026 | $373.84 | $442.23 | $537.91 | +2.56% |
| December 2026 | $384.07 | $455.88 | $557.50 | +3.09% |
Click any year to see its month-by-month UNH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, UNH could reach as high as $557.50, with a base case around $417.64 and support toward $259.02 — roughly 0% from $417.64. Price action looks broadly range-bound.
Expect UNH to range from $440.59 to $685.13 through 2027. The $537.45 average target implies a +29% move from current prices. That is up +29% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The UNH price prediction for 2028 points to an average of $590.83 (low $475.32, high $773.81) — a potential gain of +41% on today's $417.64. Momentum favours further upside here.
In 2029, UNH is projected to trade between $552.26 and $932.66, averaging $697.13 — a potential gain of +67% from today's $417.64. That is up +18% on the projected 2028 average. Buyers look set to stay in control over this stretch.
UnitedHealth Group Incorporated's 2030 outlook centres on $789.80, within a $617.29 to $1,075.79 range. That is up +13% on the projected 2029 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2031, UNH could reach as high as $1,305.33, with a base case around $943.33 and support toward $728.35 — roughly +126% from $417.64. Buyers look set to stay in control over this stretch.
Expect UNH to range from $904.42 to $1,662.67 through 2032. The $1,184.64 average target implies a +184% move from current prices. That is up +26% on the projected 2031 average. Momentum favours further upside here.
The UNH price prediction for 2033 points to an average of $1,280.63 (low $967.49, high $1,820.75) — a potential gain of +207% on today's $417.64. Buyers look set to stay in control over this stretch.
In 2034, UNH is projected to trade between $1,073.64 and $2,065.13, averaging $1,435.30 — a potential gain of +244% from today's $417.64. That is up +12% on the projected 2033 average. Momentum favours further upside here.
UnitedHealth Group Incorporated's 2035 outlook centres on $1,614.56, within a $1,196.38 to $2,348.99 range. That is up +12% on the projected 2034 average. That marks a +287% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, UNH could reach as high as $4,134.75, with a base case around $2,711.66 and support toward $1,926.36 — roughly +549% from $417.64. Momentum favours further upside here.
Expect UNH to range from $3,444.39 to $8,500.72 through 2050. The $5,200.33 average target implies a +11.5x move from current prices. That is up +92% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in UNH today (≈ 2.394407 UNH) could be worth
$12,451.7
+$11,451.7 (+1145%) by 2050 · US Dollar
Based on the average projected UNH price of $5,200.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UNHwould be worth at today's price.
$1,000 invested in UNH on Jul 28, 2025 (≈ 3.544591 UNH) would be worth
$1,480.36
+$480.36 (+48.0%) today · 1.48× · US Dollar
Based on a UNH entry price of $282.12 vs. today's $417.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $421.55 | $990.72 | -0.9% |
| 1 month ago | $427.89 | $976.05 | -2.4% |
| 3 months ago | $366.77 | $1,138.7 | +13.9% |
| 6 months ago | $294.02 | $1,420.45 | +42.0% |
| 1 year ago | $282.12 | $1,480.36 | +48.0% |
| All time (5.0y) ago | $412.08 | $1,013.49 | +1.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UNH forecast.
Our base-case forecast reaches $840.00 around 2031.
Implied market cap at $840.00: $762.84B
The multi-year forecast shows a rising trajectory from 2026 through 2050. The 2026 average price is $436.35, growing to a 2030 average of $866.08 and a 2040 average of $3,130.30, with a 2050 average of $6,076.98. Max values rise to $1,180.01 in 2030, $4,773.75 in 2040, and $9,934.71 by 2050.
ROI climbs from 0% in 2026 to 98.5% in 2030 and to 1292.7% in 2050, with bullish sentiment throughout the period. These figures reflect estimates and are not guarantees; actual results can differ and depend on many factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $866.08, a min of $676.77, and a max of $1,180.01, with an ROI of 98.5% and bullish sentiment.
The outlook is bullish in the forecast, with rising averages from 2027 onward (e.g., 2027 avg $570.14, 2028 avg $637.10, 2029 avg $755.39) and ROI reaching 98.5% by 2030 and higher later, though these are estimates and not guarantees.
Yes. The 2031 forecast shows an average of $1,049.93 with a max of $1,453.19 and an ROI of 140.6%, indicating the possibility of crossing $1,000 per share according to the projection.
The 2040 average is $3,130.30, with a min of $2,223.48, a max of $4,773.75, and an ROI of 617.4%, indicating substantial long-term upside in the projection.
Current price is $436.35 and market capitalization is $396.27B, with a rank of 27.
UnitedHealth Group Incorporated Community Discussion
0Share your UnitedHealth Group Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.